Fasting
This graph shows the total number of publications written about "Fasting" by people in the URMC Research Network by year, and whether "Fasting" was a major or minor topic of these publication.
Below are the most recent publications written about "Fasting" by people in Profiles.
-
Dimitriadis G, Hatziagelaki E, Mitrou P, Lambadiari V, Maratou E, Raptis AE, Gerich JE, Raptis SA. Effect of hyperthyroidism on clearance and secretion of glucagon in man. Exp Clin Endocrinol Diabetes. 2011 Apr; 119(4):214-7.
-
Geba D, Pearson TA. Identification of those at risk for diabetes mellitus can comparative effectiveness research provide the answer? Am J Prev Med. 2011 Jan; 40(1):101-3.
-
Aryangat AV, Gerich JE. Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk. Vasc Health Risk Manag. 2010; 6:145-55.
-
Sun SS, Schubert CM. Prolonged juvenile States and delay of cardiovascular and metabolic risk factors: the Fels Longitudinal study. J Pediatr. 2009 Sep; 155(3):S7.e1-6.
-
Woodmansee WW, Hartman ML, Lamberts SW, Zagar AJ, Clemmons DR. Occurrence of impaired fasting glucose in GH-deficient adults receiving GH replacement compared with untreated subjects. Clin Endocrinol (Oxf). 2010 Jan; 72(1):59-69.
-
Zinman B, Gerich J, Buse JB, Lewin A, Schwartz S, Raskin P, Hale PM, Zdravkovic M, Blonde L. Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD). Diabetes Care. 2009 Jul; 32(7):1224-30.
-
Stahlhut RW, Welshons WV, Swan SH. Bisphenol A data in NHANES suggest longer than expected half-life, substantial nonfood exposure, or both. Environ Health Perspect. 2009 May; 117(5):784-9.
-
Schwimmer JB, Pardee PE, Lavine JE, Blumkin AK, Cook S. Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation. 2008 Jul 15; 118(3):277-83.
-
Rademacher E, Mauer M, Jacobs DR, Chavers B, Steinke J, Sinaiko A. Albumin excretion rate in normal adolescents: relation to insulin resistance and cardiovascular risk factors and comparisons to type 1 diabetes mellitus patients. Clin J Am Soc Nephrol. 2008 Jul; 3(4):998-1005.
-
Mieszczanska H, Kaba NK, Francis CW, Gerich JE, Dodis R, Schwarz KQ, Phipps RP, Smith BH, Lee M, Messing S, Taubman MB. Effects of pioglitazone on fasting and postprandial levels of lipid and hemostatic variables in overweight non-diabetic patients with coronary artery disease. J Thromb Haemost. 2007 May; 5(5):942-9.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
